According to Amylyx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -โน13 B. In 2023 the company made an earning of โน3.25 B an increase over its 2022 earnings that were of -โน16.9 B.The earnings displayed on this page is the company's Pretax Income.